demonstrated that resistin exerted its effects on NP and AF cells through the NF‐Kβ pathway, as blocking this pathway with a specific inhibitor reduced resistin's impact on cellular pathological processes [25, 44]. The gene discussed is RETN; the disease is atrial fibrillation.